Tag: Cancer: Esophageal
Incidence of Young-Onset Esophageal Adenocarcinoma Rising
Young-onset esophageal adenocarcinoma presenting at more advanced stages; proportion of advanced stage up from 1975 to 2015
Linked Color Imaging Detects More Neoplastic Upper GI Lesions
More neoplastic lesions initially diagnosed in the examination group undergoing LCI first
Odds of Surgery Lower for Black Patients With Esophageal Cancer
Black race independently confers reduced odds of surgery; mortality higher for those without surgery
Model May Predict Barrett Esophagus Diagnosis in GERD Patients
Model validated for prediction of Barrett esophagus, with eight features showing diagnostic value
Guideline Updated for Screening, Surveillance of Barrett Esophagus
Chromoendoscopy strongly recommended for patients with Barrett esophagus undergoing surveillance
ASCO: Low-Dose Chemo Benefits Advanced Gastroesophageal Cancer
Elderly, frail receiving 60 percent of oxaliplatin/capecitabine dose have noninferior PFS, less toxicity
ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer
For patients with PD-L1 combined positive score of ≥10, pembrolizumab prolongs overall survival
Adenocarcinoma, High-Grade Dysplasia Up With Barrett Esophagus
But Barrett esophagus length has decreased, as has prevalence of low-grade dysplasia on endoscopy
Sponge Cytology-Sampling Device Promising for Barrett Esophagus Dx
Swallowable sampling device combined with methylation biomarker panel IDs Barrett esophagus
Fewer Complications Found With Hybrid Surgery for Esophageal Cancer
Incidence of intraoperative, postoperative complications lower in resectable esophageal cancer
